In depth characterization of midbrain organoids derived from wild type iPSC lines.
The ability to model human neurological tissues in vitro has been a major hurdle to effective drug development for neurological disorders. iPSC-derived brain organoids have emerged as a compelling solution to this problem as they have the potential to relevantly model the protein expression pattern...
Main Authors: | Ivan Pavlinov, Mitali Tambe, Joshua Abbott, Ha Nam Nguyen, Miao Xu, Manisha Pradhan, Atena Farkhondeh, Wei Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0292926 |
Similar Items
-
Generation and characterization of NGLY1 patient-derived midbrain organoids
by: Joshua Abbott, et al.
Published: (2023-02-01) -
A cell therapy approach based on iPSC-derived midbrain organoids for the restoration of motor function in a Parkinson’s disease mouse model
by: Chong-Lei Fu, et al.
Published: (2024-01-01) -
Merits and challenges of iPSC-derived organoids for clinical applications
by: Ziran Xu, et al.
Published: (2023-05-01) -
Sevoflurane promotes premature differentiation of dopaminergic neurons in hiPSC-derived midbrain organoids
by: Jia Shang, et al.
Published: (2022-09-01) -
Integration of iPSC-Derived Microglia into Brain Organoids for Neurological Research
by: Muhammad Asif Mrza, et al.
Published: (2024-03-01)